4.7 Article

Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations

Journal

NEUROIMAGE
Volume 118, Issue -, Pages 126-132

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.neuroimage.2015.05.077

Keywords

MRI; Brain atrophy; Diurnal change; Brain parenchymal fraction

Funding

  1. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  2. DOD ADNI [W81XWH-12-2-0012]
  3. National Institute on Aging
  4. National Institute of Biomedical Imaging and Bioengineering
  5. Alzheimer's Association
  6. Alzheimer's Drug Discovery Foundation
  7. Araclon Biotech
  8. BioClinica, Inc.
  9. Biogen Idec Inc.
  10. Bristol-Myers Squibb Company
  11. Eisai Inc.
  12. Elan Pharmaceuticals, Inc.
  13. Eli Lilly and Company
  14. EuroImmun
  15. F. Hoffmann-La Roche Ltd
  16. Fujirebio
  17. GE Healthcare
  18. IXICO Ltd.
  19. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  20. Johnson & Johnson Pharmaceutical Research & Development LLC.
  21. Medpace, Inc.
  22. Merck Co., Inc.
  23. Meso Scale Diagnostics, LLC.
  24. NeuroRx Research
  25. Neurotrack Technologies
  26. Novartis Pharmaceuticals Corporation
  27. Pfizer Inc.
  28. Piramal Imaging
  29. Servier
  30. Synarc Inc.
  31. Takeda Pharmaceutical Company
  32. Canadian Institutes of Health Research
  33. Mitacs Elevate Postdoctoral Fellowship
  34. Northern California Institute for Research and Education
  35. Genentech, Inc.

Ask authors/readers for more resources

We investigated fluctuations in brain volume throughout the day using statistical modeling of magnetic resonance imaging (MRI) from large populations. We applied fully automated image analysis software to measure the brain parenchymal fraction (BPF), defined as the ratio of the brain parenchymal volume and intracranial volume, thus accounting for variations in head size. The MRI data came from serial scans of multiple sclerosis (MS) patients in clinical trials (n = 755, 3269 scans) and from subjects participating in the Alzheimer's Disease Neuroimaging Initiative (ADNI, n = 834, 6114 scans). The percent change in BPF was modeled with a linear mixed effect (LME) model, and the model was applied separately to the MS and ADNI datasets. The LME model for the MS datasets included random subject effects (intercept and slope over time) and fixed effects for the time-of-day, time from the baseline scan, and trial, which accounted for trial-related effects (for example, different inclusion criteria and imaging protocol). The model for ADNI additionally included the demographics (baseline age, sex, subject type [ normal, mild cognitive impairment, or Alzheimer's disease], and interaction between subject type and time from baseline). There was a statistically significant effect of time-of-day on the BPF change in MS clinical trial datasets (-0.180 per day, that is, 0.180% of intracranial volume, p=0.019) as well as the ADNI dataset (-0.438 per day, that is, 0.438% of intracranial volume, p < 0.0001), showing that the brain volume is greater in the morning. Linearly correcting the BPF values with the time-of-day reduced the required sample size to detect a 25% treatment effect (80% power and 0.05 significance level) on change in brain volume from 2 time-points over a period of 1 year by 2.6%. Our results have significant implications for future brain volumetric studies, suggesting that there is a potential acquisition time bias that should be randomized or statistically controlled to account for the day-to-day brain volume fluctuations. (C) 2015 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available